Neonc Technologies (NASDAQ:NTHI) Posts Quarterly Earnings Results

Neonc Technologies (NASDAQ:NTHI) posted its quarterly earnings results on Friday. The company reported ($2.10) EPS for the quarter, Zacks reports. The company had revenue of $0.04 million during the quarter.

Neonc Technologies Stock Performance

NASDAQ NTHI opened at $7.34 on Friday. Neonc Technologies has a 52 week low of $4.11 and a 52 week high of $25.00.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.